Best of heart failure

N O A U T H O R C H A R G E S F O R C O L O R P R I N T I N G HEART FAILURE REVIEWS HEARTFAILUREREVIEWS Springer Volume 23 Number1 January 2018 13 10741 • ISSN1382-4147 23(1)1–146 (2018) V O L U M E 2 3 — N U M B E R 1 — J A N U A R Y 2 0 1 8 Sidney Goldstein,M.D. and Hani N. Sabbah,Ph.D. Editors springer.com/ebooks Springer eBooks Theworld’s largestcollectionofSTMbooks • Critical,must-havecontent • Continuousaccesswitharchival rights • NoDRM–no limitonusers,printing& downloads • AllonSpringerLink–anytime,anywhere, anydevice 015420x springer.com #Books Change Volume 44 •Number 4 •November 2017 Catheter ablation forAF improves global thrombotic profile and enhances fibrinolysis Reducing catheter-related thrombosis using a risk reduction tool centered on catheter to vessel ratio High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy N-terminal pro-B-type natriuretic peptide and the risk of stroke among patients hospitalizedwith acute heart failure:anAPEX trial substudy Effects of purified human fibrinogenmodifiedwith carbonmonoxide and iron on coagulation in rabbits injectedwith Crotalus atrox venom A systematic review of cost-effectiveness analysis of screening interventions for assessing the risk of venous thromboembolism inwomen considering combined oral contraceptives Highlights from theNinth International Symposium ofThrombosis andAnticoagulation (ISTA IX),October 15,2016,Salvador,Bahia,Brazil 11239 • 44(4) 413–570 (2017) ISSN 0929-5305 (Print) ISSN 1573-742X (Electronic ) Springer V O L U M E 4 4 — N U M B E R 4 — N O V E M B E R 2 0 1 7 JournalofThrombosisandThrombolysis Journal of THROMBOSIS and THROMBOLYSIS AJournal forTranslation,ApplicationandTherapeutics inThrombosisandVascularSci ence JournalofThrombosis andThrombolysis A Journal forTranslation,Application andTherapeutics in Thrombosis andVascularScience Volume 44 · Number 4 · November 2017 Fordetailed tableof contentsplease see inside CurrentAtherosclerosisReports 2017Vol19No12 CURRENT ATHEROSCLEROSIS REPORTS EDITOR-IN-CHIEF Antonio M. Gotto Jr ASSOCIATEEDITOR Anders G. Olsson VOLUME 19 I NUMBER12 I DECEMBER 2017 Genetics and Genomics Section Editor ■ Ali J. Marian Lipid and Metabolic Effects of Gastrointestinal Surgery Section Editor ■ Ricardo Cohen Statin Drugs Section Editor ■ Barbara Wiggins Cardiovascular Disease and Stroke Section Editor ■ Shyam Prabhakaran Vascular Biology Section Editor ■ James Hamilton Nonstatin Drugs Section Editor ■ Emil deGoma 13 Genetics andGenomics / Lipid andMetabolicEffects ofGastrointestinalSurgery /StatinDrugs /CardiovascularDisease andStroke /VascularBiology /NonstatinDrugs CURRENT CARDIOLOGY REPORTS EDITOR-IN-CHIEF Steven E. Nissen ASSOCIATEEDITOR Raimund Erbel CurrentCardiologyReports is indexedbyMEDLINE InvasiveElectrophysiologyandPacing SectionEditor ■ E.KevinHeist Stroke SectionEditor ■ James F.Meschia CardiovascularGenomics SectionEditor ■ Themistocles L.Assimes ValvularHeartDisease SectionEditor ■ ToddKiefer CardiacPET,CT,andMRI SectionEditors ■ FrancescaPugliese andSteffenE.Petersen Hypertension SectionEditors ■ DavidS.Geller andDebbie L.Cohen Heart Failure SectionEditor ■ Howard J.Eisen Echocardiography SectionEditors ■ JuliusM.Gardin andAlfonsoH.Waller VOLUME 19 I NUMBER 12 I DECEMBER 2017 13 InvasiveElectrophysiology andPacing /Stroke /CardiovascularGenomics /ValvularHeartDisease /CardiacPET,CT,andMRI /Hypertension /Heart Failure /Echocardiography 2017Vol 19No12 CurrentCardiologyReports Volume107 •Number1 • January2018 123 Clinical Research in Official Journalof theGermanCardiacSociety Cardiology ChiefEditors M.Böhm,Homburg/Saar H.A.Katus,Heidelberg AssistantEditors R.Bekeredjian,Heidelberg S.Ewen,Homburg/Saar ConsultingEditors T.Eschenhagen,Hamburg G.Heusch,Essen 392 ClinicalResearch inCardiology Volume107 •Number1 • January2018 • pp.1–94 ° FÜR SICH SELBSTWÜRDEN SIEAUCHAUF WIRKSAMKEIT UND VERTRÄGLICHKEIT 1* VERTRAUEN ELIQUIS ® verbindet beides G #11#0# '0)1 +)#'241@ 0$ 0', 1* G5#,'%#01!&5#0# *323,%#,41@ 0$ 0', 1* ? 30 !&* % ,$ **.0-.&7* 6# #' R 2'#,2#, # '#2#2 ® %*#'!&8#'2'%#',#1'%,'l) ,2ɻ #0*#%#,# #"3)2'-,4-, !&* % ,$ȥ**#,H1712#+'1!&#, + -*'#,3,"5#,'%#01!&5#0# *323,%#,41@ 0$ 0', 1‡ î 2'#,2#,+'2,'!&2R4*43*ȥ0#+-0&-r'++#0,3,"#',#+-"#0+#&0#0#,'1')-$)2-0#,@ X !&5#0#*323,%50#',5'!&2'%#01#)3,"ȥ0#0,".3,)2',"#0 R23"'#3,"530"##,21.0#!&#,"#',#04-0 $#12%#*#%2#,&'#00!&'1!&#,#12R202#%'#%#2#12#2A3+"#,7.RR#&*#0',"#023"'# +ɢ%*'!&12,'#"0'%83&*2#,@ Literaturangaben:1. 0,%#0 et al @ ,%* #"àÞßßCáäãBçæßTççà@ Eliquis2,5mg '*+2 *#22#,@ Eliquis5mg '*+2 *#22#,@ Wirkstoff: .'6 ,@ Zusammensetzung: '0)12-nBàAã+% 85@ã+%.'6 ,@-,12@#12,"2#'*#B !2-1#A ')0-)0'12**',##**3*-1#A0-1!0+#**-1#R 20'3+A 20'3+"-"#!7*13*$2A %,#1'3+12#02A !2-1#R-,-&7"02A 7.0-+#**-1#A'2,"'-6'"A0'!#2',A*'/3'1àAã+%831ȥ28*'!&B'1#,IKR&7"0-6'"R-6'"6 à C*'/3'1ã+%831ȥ28*'!&B'1#,IKR-6'"@ Anwendungsgebiete: 0-.&7*6#4@!&*%,$ȥ**#,3@1712#+'1!&#,+ -*'#, #'#05@ 2@+'2,'!&2R4*43*ȥ0#+-0&-r'++#0,3@#',#+-@+#&0#0#,'1')-$)2-0#,A5'#!&*%,$**-@ ',"#0,+,#1#A*2#0ýåã &0#,A7.#02-,'#A' #2#1 +#**'231A17+.2-+2'1!&##08',13o8'#,8I *11#ýK@#&,"*3,%4@2'#$#,#,#,2&0-+ -1#,I K3@3,%#,#+ -*'#,I K1-5'#0-.&7*6#4@0#8'"'4'#0#,"#, 3," #'05@*'/3'1àAã+%831ȥ28*'!&B0-.&7*6# 4#,ɢ1#0&0-+ -#+ -*'#, #'#05@ 2@,!&#*#)2'4#,ɻyR-@,'#%#*#,)1#0128-.#02'-,#,@ Gegenanzeigen: Ȑ #0#+.l,"*'!&)#'2%%@"#, '0)12-n-@#@"@1-,12@#12,"2#'*#C)32#)*','1!&0#*#4,2#*323,%C# #0#0)0,)3,%#,A "'#+'2#',#0-%3*-.2&'#3@#',#+)*','1!&0#*#4,2#,*323,%10'1')-4#0 3,"#,1',"@ȥ1'-,#,-@)*','1!&#'232'-,#,A$**11'#*11'%,'l),2#0'1')-$)2-0$ɻ0#',#1!&5#0#*323,%,%#1#&#,5#0"#,I8@@)32#-@)ɻ08*@ 3$%#20#2#,#%120-',2#12',*#*8#02'-,#,A+*'%,##-.*1'#,+@&-&#+*323,%10'1')-A)ɻ08*@3$%#20#2#,#'0,R-@ɻ!)#,+0)14#0*#283,%#,A)ɻ08*@#0$-*%2#!&'030%'1!&# ',%0'n#,#&'0,Aɻ!)#,+0)-@3%#,A)ɻ08*@3$%#20#2#,#',20)0,'#**#*323,%#,A #),,2#-@4#0+32#2#Ǹ1-.&%3140'8#,A02#0'-4#,ɢ1##&* '*"3,%#,A41)3*ȥ0# ,#3071+#,-@%0ɢɲ#0#',201.',*#-@',208#0# 0*#41)3*ȥ0#,-+*'#,@*#'!&8#'2'%#,5#,"3,%,"#0#0,2')-%3*,8'#,8@@3,$0)2'-,'#02# #.0',#A,'#"#0+-*@ #.0',#A#.0',"#0'42#A-0*#,2')-%3*,8'#,3ɲ#0 #'+12#**3,%"#0,2')-%3*2'-,4-,-@3$.'6 ,-@3,$0)2'-,'#02#1#.0',',-1#,A3+"'#30!&%ȥ,%'%)#'2 #@8#,20*4#,ɢ1#,-@02#0'#**#, 2&#2#0183#0&*2#,@ Nebenwirkungen: Häufig: ,ȥ+'#C*323,%#,+3%#I#',1!&*'#ɲ*'!&',"#&32 *323,%KC*323,%#,A ȥ+2-+#C .'126'1CȐ #*)#'2C 120-',2#12',*#*323,%C#)2* *323,%A &,m#'1!& *323,%Cȥ+230'#C-,231'-,@ Gelegentlich: &0-+ -872-.#,'#CȐ #0#+.l,"*'!&)#'210#)2'-,#,A **#0%'1!&#1Ǹ"#+A,.&7*)2'1!&##)2'-,C030'231C#&'0, *323,%C7.-2-,'#I#',1!&*'#ɲ*'!&*32"03!) $**5ȥ&0#,""#1',%0'n1KC,20 "-+',* *323,%Cȥ+-.271#C ȥ+-00&-'"* *323,%A*323,%'+ 3,"03+Aȥ+2-!&#8'#C0&ɢ&3,%"#00,1+',1#,A#0&ɢ&2#1.022R+',-20,1$#01#A#0&ɢ&2#ύR*32+7*20,1$#01#A ,-0+*# # #0$3,)2'-,12#121A#0&ɢ&2#*325#02#$ɻ0*)*'1!&#&-1.&21#A#0&ɢ&2#*325#02#$ɻ0'*'03 ',C 3231!&*%C ,-0+*#4%',*#*323,%A30-%#,'2*#*323,%C*323,% ,"#0..*')2'-,112#**#C ))3*2#1*32.-1'2'4C-12-.#02'4#*323,%I#',1!&*'#ɲ*'!&.-12-.#02'4#1 ȥ+2-+A 3," *323,%A ȥ+2-+, #$ȥɲ.3,)2'-,112#**#3," *323,%,"#0 2&#2#0#',12'!&12#**#KA 3,"1#)0#2'-,A*323,%#,,"#0,8'1'-,112#**#I#',1!&*'#ɲ*'!&ȥ+2-+,"#0,8'1'-,112#**#KA',20-.#02'4#*323,%C03+2'1!&# *323,%A*323,%,!&#',#+',%0'nA*323,%,#',#0,8'1'-,112#**#@ Selten: *323,%"#02#+5#%#C#20-.#0'2-,#*#*323,%C 31)#* *323,%C WeitereHinweise: 1'#&# !&',$-0+2'-,@ #01!&0#' 3,%1.m'!&2'%@ Pharmazeutischer Unternehmer: 0'12-*R7#01/3' Hl8#0 A 0'12-*R7#01/3' -31#A 6 0'"%# 31',#11 0)A ,"#01-,-"A6 0'"%#A '""*#1#6 æß #0#','%2#1ɢ,'%0#'!&@ Stand: ßHàÞßä 2018,Vol. 18,No. 1 (pp. 1–74) ISSN: 1175-3277 (Print); 1179-187X (Online) ReviewArticles Macitentan inCombinationTherapy forPAH Pharmaceutical Interventions forDiabetesPrevention Benefit-RiskAssessment of Crataegus ExtractWS1442 OriginalResearchArticles Selexipag inPAHPatientsReceivingTwoDrugs PreventingAcuteKidney InjuryAfterCardiacSurgery ShortCommunications Ivabradine inPOTS:PreliminaryExperience inChildren LifestyleCounseling andPrescribing forHyperlipidemia ResearchLetter Long-TermFollow-up ofCoronarySlowFlowPhenomenon Adis American Journalof Cardiovascular Drugs DRUGS,DEVICESANDOTHER INTERVENTIONS Official Journalof the InternationalAcademyofCardiovascularSciences American JournalofCardiovascularDrugs ·2018,Vol.18,No.1,pp.1–74 adis.com 2017,Vol.24,No.4 (pp.351–550) ISSN: 1120-9879 (Print); 1179-1985 (Online) HighBloodPressure&CardiovascularPrevention · 2017,Vol.24,No.4,pp.351–550 High Blood Pressure & Cardiovascular Prevention Official journalof Società Italianadell’IpertensioneArteriosa Arteriosa Lega Italiana contro l’Ipertensione Editorial TocciGiuliano,Educational InterventionsMayPromoteBetterBloodPressureControl inRussia ReviewArticles GerliRoberto,Roleof InflammatoryDiseases inHypertension StabileEugenio,HypertensionSurvey in Italy:NovelFindings from theCampaniaSaluteNetwork OriginalArticles ZócaloYanina,ChildrenandAdolescentsMacrovascularReactivityLevelandDynamics,ButNot the MicrovascularResponse, isAssociatedwithBodyMass IndexandArterialStiffnessLevels ShiberShachaf,CanDiastolicBloodPressureDecrease inEmergencyDepartmentSettingbeAnticipated? GrassiGuido,Long-termSaxagliptinTreatment ImprovesEndothelialFunctionbutnotPulseWave Velocityand Intima-MediaThickness inType2DiabeticPatients VolpeRoberto,Hypertriglyceridemia,anUnderestimatedCardiovascularRiskFactor:AnEpidemiological Studyof theRomeArea LiShijun,PrognosticSignificanceofLowSystolicBloodPressureatDischarge inPatientswithHeart FailureandPreservedEjectionFraction SalvoFrancesco,NocturnalBloodPressureDipping isAbolished inOld-ElderlyHospitalizedPatients DelBruttoOscar,TheRoleofBrachialPulsePressureasan Indicatorof IntracranialAtherosclerosis: TheAtahualpaProject KiselevA, ImpactofClinicalFactorson theAchievementofTargetBloodPressure inHypertensive Patients from IvanovoRegionofRussia:Dataof2015 ZócaloYanina,ComparativeAnalysisofArterialParametersVariationsAssociatedwith Inter-Individual Variations inPeripheralandAorticBloodPressure:Cross-SectionalStudy inHealthySubjectsAged2–84years KhalesiSaman,DietaryPatterns,NutritionKnowledge,Lifestyle,andHealth-RelatedQualityofLife: AssociationswithAnti-HypertensionMedicationAdherence in aSampleofAustralianAdults PositionPaper VolpeMassimo,PersonalisedSingle-PillCombinationTherapy inHypertensivePatients: AnUpdateof aPracticalTreatmentPlatform Letter to theEditor ScullinEvan,Response to ImprovingAdherence toTreatment andReducingEconomicCosts ofHypertension:TheRoleofOlmesartan-BasedTreatment Abstracts SelectedAbstractsFromXXXIVNationalCongressof the ItalianSocietyofHypertension (SIIA), Milan,5–7October2017 Adis Publisherof: Adis Journals American JournalofCardiovascularDrugs American JournalofClinicalDermatology AppliedHealth Economics andHealthPolicy BioDrugs ClinicalDrug Investigation ClinicalPharmacokinetics CNSDrugs DrugSafety Drugs Drugs&Aging Drugs&TherapyPerspectives Drugs inR&D (OpenAccess) European JournalofDrugMetabolism and Pharmacokinetics HighBloodPressure&CardiovascularPrevention MolecularDiagnosis&Therapy PediatricDrugs PharmaceuticalMedicine PharmacoEconomics TargetedOncology ThePatient:Patient-CenteredOutcomes Research AdisRapid+ Journals (OpenAccess) Advances inTherapy (OpenChoice) Biologics inTherapy Cardiology andTherapy Dermatology andTherapy DiabetesTherapy InfectiousDiseases andTherapy Neurology andTherapy Ophthalmology andTherapy Pain andTherapy RareCancers andTherapy Rheumatology andTherapy Adis Local-language Journals PharmacoEconomics ItalianResearchArticles PharmacoEconomicsSpanishResearchArticles AdisNewsletters PharmacoEconomics&OutcomesNews ReactionsWeekly AdisDatabases ClinicalTrials Insight Pharmacovigilance Insight R&D Insight AdisBooks Booksondrugsand relatedtopicsaswellasthepathogenesis, diagnosis and clinicalmanagementofdisease THEHEART INSPACE Effectsofmicrogravityandradiation ontheheartandvasculature Marijuanaand synthetic cannabinoids Influenceonthecardiovascularsystem CARDIOLOGY March2018volume15no.3 www.nature.com/reviews T D C CARDIOVASCULAR DRUGS AND THERAPY CardiovascularDrugs andTherapy Volume 31, Issues 5-6, 2017 pp.485–644 Springer Editors-in-Chief:Willem J.Remme andRobertS.Rosenson Listed inCurrentContents and IndexMedicus Volume 31,Nos.5-6, 2017 ISSN 0920-3206 13 this issue includes: Editorial Find andPlug the Leak: ImprovingAdherence toAnti-HypertensiveMedicines BasicPharmacology Unraveling the InteractionofAspirin,Ticagrelor,andRosuvastatinonProgressionofAtherosclerosis and Inflammation inDiabetes NovelSynthesizedRadical-ContainingNanoparticles Limit InfarctSize Following Ischemi/-Reperfusion SodiumThiosulfatePreconditioningAmeliorates I/R InjuryViaReduction ofOxidativeStress andApoptosis ANewClass IIIAntiarrhythmicDrugNiferidilProlongsActionPotentials inAtrialMyocardium viaRapidDelayedRectifier Inhibition ClinicalPharmacology andDrugStudies Diuretic orBeta-Blocker forHypertensivePatientsAlreadyReceivingACEI/ARB andCalcium ChannelBlocker ClinicalTrials Prevalence ofPrediabetes andUndiagnosedDiabetes inPatientswithHFpEF andHFrEF andAssociatedClinicalOutcomes (continued at the back cover) Heart Failure (LASCAR-AHF) ducedEjection Fraction inNamibia:Findings olecularTargets dData inReview es U HEEFT EEN DOEL U KIEST DE KRACHT KIES DE KRACHT 1 Productinformatie en referenties elders indezeuitgave.SANL.ALI.17.03.0145 Volume26 January2018 Goldopenaccess Outcomesof coronaryvasospasm Volunteeralert system 1 Volume 33 Number 1 January 2018 K. Yonezu, K. Sakakura, Y.Watanabe, Y. Taniguchi, K. Yamamoto,H.Wada, S.Momomura,H. Fujita Determinants of survival and favorable neurologic outcomes in ischemic heart disease treated by veno-arterial extracorporeal membrane oxygenation 25 K. Yamamoto, K. Sakakura,N. Akashi, Y.Watanabe, M.Noguchi, Y. Taniguchi,H.Wada, S.Momomura, H. Fujita Clinical outcomes of leftmain crossover stenting for ostial left anterior descending artery acutemyocardial infarction 33 N.Onishi, K. Kaitani,M. Amano, S. Imamura, J. Sakamoto, Y. Tamaki, S. Enomoto, M.Miyake, T. Tamura,H. Kondo,C. Izumi, Y.Nakagawa Relationship between left ventricular diastolic dysfunction and very late recurrences aftermultiple procedures for atrial fibrillation ablation 41 Original articles j Clinical investigations K.Matsuura,H.Ueda,H. Kohno, Y. Tamura, M.Watanabe, T. Inui, Y. Inage, Y. Yakita, G.Matsumiya Does the presence of coronary artery disease affect the outcome of aortic valve replacement? 1 M. Komiyama,H.Wada, K.Ono,H. Yamakage, N. Satoh-Asahara, S. Shimada,M. Akao, T.Morimoto, A. Shimatsu, Y. Takahashi, T. Sawamura,K.Hasegawa Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular riskmarker of vascular inflammation 9 M.-N. Kim,H.-L. Kim, S.-M. Park,M.S. Shin, C.W. Yu,M.-A. Kim, K.-S.Hong,W.-J. Shim Association of epicardial adipose tissuewith coronary spasm and coronary atherosclerosis in patientswith chest pain: analysis of data collated by theKoReanwOmen’S chest pain rEgistry (koROSE) 17 380Heart Vessels ISSN 0910-8327HEVEE 0 33(1) 1–94 (2018) Heart and Vessels Vol. 33 No. 1 2018 pp. 1–94 380 Contents continued in back cover j Basic science E. Luyckx, B.R. Everaert, B. Van der Veken, W. Van Leuven, J.-P. Timmermans,C.J. Vrints, G.R.Y.DeMeyer,W.Martinet, S.Dewilde Cytoprotective effects of transgenic neuroglobin overexpression in an acute and chronicmouse model of ischemic heart disease 80 Short communication M. Kuwabara, K.Niwa,U. Yamada,D.Ohta Low bodymass index correlateswith low left ventricularmass index in patientswith severe anorexia nervosa 89 Y.Hen,M. Tsugu-Yagawa,N. Iguchi, Y.Utanohara, K. Takada,H.Machida, A. Takara, K. Teraoka, K. Inoue, I. Takamisawa,M. Takayama, T. Yoshikawa Prognostic value of cardiovascularmagnetic resonance imaging for life-threatening arrhythmia detected by implantable cardioverter-defibrillator in Japanese patientswith hypertrophic cardiomyopathy 49 V. Roule, A. Placente, R. Sabatier,M. Bignon, V. Saplacan,C. Ivascau, P.Milliez, F. Beygui Angles between the aortic root and the left ventricle assessed byMDCT are associatedwith the risk of aortic regurgitation after transcatheter aortic valve replacement 58 X. Sun,H. Yang, X. Li, Y.Wang,C. Zhang, Z. Song, Z. Pan Randomized controlled trial ofmoderate hypothermia versus deep hypothermia anesthesia on brain injury during StanfordA aortic dissection surgery 66 K. Furukawa,M. Yano, E.Nakamura,M.Matsuyama, M.Nishimura, K. Kawagoe, K.Nakamura Comparison ofmitral competence aftermitral repairwith papillarymuscle approximation versus papillarymuscle relocation for functionalmitral regurgitation 72 Contents continued Indexed in IndexMedicus,CurrentContents, EMBASE JANUARY2018 Vol.33 No.1 CARDIOVASCULAR INTERVENTION AND THERAPEUTICS Vol.33 No.1 January 2018 PP 1–98 12928 VOLUME19 I NUMBER12 I DECEMBER 2017 Imaging Section Editor ■ Q. Truong Pregnancy and Cardiovascular Disease Section Editor ■ N. Scott Current Treatment Options in CARDIOVASCULAR MEDICINE EDITOR-IN-CHIEF Jagmeet P. Singh Imaging / Pregnancy and Cardiovascular Disease 2017 Vol 19 No 12 Current Treatment Options in CardiovascularMedicine A SNC tely T r ice management. b82Generator):Generating formore than25years. Typical 82 Rb ECG-GatedRest-Stress AcquisitionProtocol for a Line-Source orHybridPET/CTSystem 1 TxScan EmissionScan,3DwithGating Pharmacologic Stress 1 min 3.5 mins 1 min 3.5 mins Rb-82 40mCi Rb-82 40mCi TotalProtocolCompletionTimeApprox. 30mins ration.RubidiumRb 82 chloride injection is indicated for ardial perfusion in adult patientswith suspected or existing 85)RADIATIONEXPOSURE [seeWarnings andPrecautions (5.1)] . age andAdministration (2.4)] . L [seeDosage andAdministration (2.5)] . ia,hypotension,bronchoconstriction,and ion and only in the settingwhere cardiac ll 1-800-FDA-1088. adjacentpage. edi-Physics, Inc.,SouthPlainfield,NJ07080 ) to find outwhat hundreds w: We are CardiacPET. ™ .SenthamizhchelvanS,BravoPE,EsaiasC,et al.Human osimetry of82Rb in humans under pharmacologic stress. al perfusion positron iology and Society of (10):1654- 1656. Nuclear MedicineSuite Volume24 •Number6 November/December2017 Journal of Nuclear Cardiology OfficialPublicationof the AmericanSocietyofNuclearCardiology pgs1835–2146 JournalofNuclearCardiology 12350 •24(6)1835–2146 (2017) ISSN1071-3581 23 V O L U M E 2 4 — N U M B E R 6 — N O V E M B E R - D E C E M B E R 2 0 1 7 OriginalArticles 1850 Current statusof stressmyocardial perfusion RyutoOtsuka,KazukiFukuchi,etal. 1860 Extra-cardiac findingsonmyocardial PET/CT H.Kan,R.J.J.Knol,etal. *Thisarticle includesSpanish,Chineseand Frenchabstracts. 1912 Overweightedpatientsundergoing myocardial spect JennyOddstig,HenrikEngblom,etal. 1926 EffectivenessofASV therapy forCHF withCSR TakujiToyama,ShigeruOhsima,etal. 1941 Respiratorygating incardiacPET MartinLyngbyLassen,PhilipHasbak,etal. 1966 Prognostic significanceofblood pressure responseduringvasodilator stress BradleyWitbrodt,LesleeJ.Shaw,etal. 1979 Effectsofanendothelin receptor antagonist,Macitentan KatarzynaDrozd,LisaM.Mielniczuk,etal. 1998 Quantifyingpredictiveaccuracy in survivalmodels SethT.Lirette, InmaculadaAban Please seepg.3A fora full listing of theTableofContents. Please seepg.8Aandpg.9A for the featuredartwork, quotesandpoem. Editor’sPage 1835 Coronaryvascularagecomesofage AlbertoCuocolo,MarioPetretta,etal. ReviewArticles 1837 JNCquickglanceNovember2017 PradeepBhambhvani,AmiE. Iskandrian,etal. 1893 Guidelines in review AlejandroVelasco,FadiG.Hage,etal. 1902 Erratum to:Guidelines in review AlejandroVelasco,FadiG.Hage,etal. 2004 Chestpain triage inUSA MatthewC.DeLaney,JaredJ.Thomas,etal. Reviewof theLiterature 1840 Nuclearcardiology in the literature: A selectionof recent,original research papers SaurabhMalhotra,PremSoman 1842 Cardiovasculardisease in the literature FadiG.Hage,WaelAlJaroudi What is this Image? 1845 What is this Image?2017: Image4 1846 What is this Image?2017: Image3Result HistoryCorner 1848 GeorgeDeHevesy,Recipientof the 1943NobelPrize forChemistry H.WilliamStrauss,AvijitLahiri,etal. Editorials 1856 Reducing radiationexposure from nuclearmyocardialperfusion imaging AnkurGupta,NavkaranbirS.Bajaj 1869 Incidentalextra-cardiac findingson 13 NH 3 myocardialperfusionPET/CT Andrei Iagaru 1878 ThePrivatePracticeCorner AndrewJ.Einstein,RandallC.Thompson 1904 Comparing theAHA/ACCandESC guidelines for themanagementofpatients SaurabhMalhotra,JohnM.CantyJr. 1909 Europeanperspective:Comparing the AHA/ACCandESCguidelines FrankM.Bengel 1922 It’sabout timewe thinkabout lowering radiationdose inobesepatients too DanielA.Kim,ScottD.Jerome,etal. 1938 Sympatheticnervous system, systolic heart failureandcentral sleepapnea OlivierLairez,DenisAgostini,etal. 1950 Optimizingquantitativemyocardial perfusionbyPET K.LanceGould 1965 Perfusiondebate H.WilliamStrauss 1976 Bloodpressure response tovasodilator stress ElianaReyes,FadiG.Hage 1990 Assessmentofrightventricularmetabolism AttilaFeher,AlbertJ.Sinusas 1994 Designand interpretationof non-inferiority studies ToddM.Brown 2012 Imaging forchestpain in theemergency room DavidG.Wolinsky ThemeArticle 1871 Reducing radiation topatientsand improving imagequality StephenA.Bloom,KarenMeyers ReviewArticle–CMEArticle 1880 CME Information 1883 PETMBFpostMI HenryGewirtz Seepage1864 Springer Nature Cardiology Journals 40119 eISSN:2193-6544 Volume6 | Issue2 |December |2017 40119 Volume6 | Issue2 |December |2017 Editor-in-Chief (Interventional Cardiology) IanMenown Editor-in-Chief (Europe) UweZeymer Editor-in-Chief (USA) RobertGiugliano Cardiology and Therapy Openaccess Rapidpublication Enhanced features www.cardiologytherapy-open.com REVIEWS 157 HeartDiseaseandPregnancy R.Ashrafi ·S.L.Curtis 175 LeadlessPacing:CurrentStateandFutureDirection M.Merkel ·P.Grotherr ·A.Radzewitz ·C.Schmitt 183 FromCoreValve toEvolutPRO:Reviewing theJourneyofSelf-Expanding TranscatheterAorticValves D.Mahtta · I.Y. Elgendy ·A.A.Bavry 193 RecentTrends inClotRetrievalDevices:AReview A.Hameed ·H.Zafar ·D.Mylotte · F.Sharif 203 ManagementandPreventionofSaphenousVeinGraftFailure:AReview P.McKavanagh ·B.Yanagawa ·G.Zawadowski ·A.Cheema 225 Exosomes inCardiovascularMedicine I.M.Dykes ORIGINALRESEARCH 239 TreatmentofStableAnginawithaNewFixed-DoseCombinationof Ivabradine andMetoprolol:EffectivenessandTolerability inRoutineClinicalPractice D.Divchev ·G.Stöckl ·Onbehalfof the study investigators 251 ComparisonofDifferent InvasiveHemodynamicMeasurementsasaPrediction Tool forMortalityafterTranscatheterAorticValveReplacement inMen: ARetrospectiveObservationalStudy A.A.Bavry ·S.H.Aalaei-Andabili ·A.Karimi ·K.Park ·C.Y.Choi · E.W.Manning III · T.M.Beaver ·W.W.Stinson 261 AnalyticalManagementofPatientsUndergoingOralAnticoagulantTherapyCould HaveaStrong ImpactonClinicalOutcomes:AFollow-upStudy V.De Iuliis ·S.Ursi ·G.Vitullo · I.Griffo ·A.Marino ·M.Caruso · F.Cipollone · S.Capodifoglio ·V.Breda · E.Toniato ·A.Pennelli ·P.Conti ·S.Martinotti 273 MedicalTherapyandRecurrent IschemicEvents inHighRiskPatientsSurviving theirMyocardial Infarction foratLeast12Months:ComparisonofPatientswith STElevationVersusNon-STElevationMyocardial Infarction U.Zeymer ·K.Riedel ·M.Hahn 281 ElevatedCirculatingPCSK9ConcentrationsPredictSubclinicalAtherosclerotic Changes inLowRiskObeseandNon-ObesePatients Š.Tóth · J. Fedacˇko ·T.Pekárová ·Z.Hertelyová ·M.Katz ·A.Mughees · J.Kuzma · P.Štefanicˇ · I.Kopolovets ·D.Pella (Continuedonoutsidebackcover) (Contentscontinued)